Effectiveness of monovalent rotavirus vaccine in Bolivia: case-control study
- Publisher:
- Gavi Alliance
- Publication Date:
- 19 June 2013
- Tags:
- Africa, Health and Medicine
This study, funded by the GAVI Alliance, examined the impact of introducing the rotavirus vaccine Rotarix® (manufactured by GlaxoSmithKline) into the national immunization program of Bolivia, a lower-middle income country in Latin America. The findings provide the evidence other low and lower-middle income countries, such as those in sub-Saharan Africa, need to evaluate whether rotavirus vaccines are right for their children.
